Dr. Shawn James Mendonca, MD

Dr. Mendonca practices at Gastrointestinal Specialists in Woodbridge, Virginia.

Dr. Mendonca's NPI, 1619219052, was assigned on March 24, 2013. Dr. Mendonca graduated from Michigan State University College of Human Medicine in 2013. Dr. Mendonca holds Virginia license 0101280217.

Dr. Mendonca's primary practice is Gastrointestinal Specialists, at 2296 Opitz Blvd Suite 350 Suite 350, Woodbridge, VA 22191-3346. The practice phone is (703) 680-2111.

Dr. Mendonca's primary practice is Gastrointestinal Specialists in Woodbridge, Virginia. Dr. Mendonca is also affiliated with Sentara Northern Virginia Medical Center. The medical group on file is Gastrointestinal Specialists, Inc. Dmand AI also links Dr. Mendonca to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mendonca practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Mendonca's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Mendonca's licenses on file in 3 states: Virginia, New York and Pennsylvania.

CMS data shows 1,942 Medicare services from Dr. Mendonca across 27 procedure codes in 2024, for 647 Medicare patients. Medicare paid $132,275 for them.

CMS counts 647 Medicare patients who saw Dr. Mendonca in 2024. The largest group is 65 to 74, with 276 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mendonca's median patient age at 61, with 24% women.

In 2024, Dr. Mendonca wrote 1,061 Medicare Part D claims for 435 patients. 87% of them were for generic drugs. CMS names the drug for 959 of them, across 17 drugs with 11 or more claims each, at $124,807 in total drug cost. In 2023, CMS named 1,154 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Mendonca for performance year 2024, reported as part of a group. Dr. Mendonca accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mendonca as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Mendonca, published from 2018 to 2022. The most frequent topics are Urethra, Mouth Mucosa and Urethral Stricture. Dr. Mendonca has published most often in J Urol. Dr. Mendonca's most frequent co-authors are Steven Benjamin Brandes, MD, Ruth Blum, MD and Jonathan Andrew Coleman, MD.

CMS Open Payments shows 120 general payments to Dr. Mendonca from 23 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 96% of the total. Medtronic, Inc. paid the most, $506.

Dr. Mendonca graduated from Michigan State University College of Human Medicine in 2013.